(S)-5-(4-(3,5-Dimethylisoxazol-4-yl)-2-(pyrrolidin-3-yloxy)phenyl)-2-ureidothiophene-3-carboxamide, 98%, 10mg

(1R,2S,5S)-3-((S)-2-(3-(1-(tert-butylsulfonylmethyl)cyclohexyl)ureido)-3,3-dimethylbutanoyl)-6,6-dimethyl-3-azabicyclo[3.1.0]hexane-2-carboxylic acid, 98%, 50mg

2,4-Diamino-6-diallylamino-1,3,5-triazine>98.0%(HPLC)(T)25g

Methyl-1,2,3-benzotriazole-5-carboxylate, 95.0%, 1g

9H-Fuoroene-9-carboxylic acid, 95.0%, 500g

5-(4-Bromo-2-fluorophenyl)-1,3,4-thiadiazol-2-amine, 95.0%, 250mg

Piperidine, min. 99%, for synthesis, 250 ml, glass packaging

(S)-2-((TERT-BUTOXYCARBONYL)AMINO)-4-(DIMETHYLAMINO)-4-OXOBUTANOIC ACID, 95.0%, 1g

6-(Dimethylamino)picolinic acid, 95.0%, 250mg

1-Methoxy-2-methyl-3-nitrobenzene, 97.0%, 10g

5-Methyl-2-(3-trifluoromethyl-phenylamino)-thiazole-4-carboxylic acid ethyl ester, 95.0%, 1g

1-(2-Hydroxyphenyl)-3-phenylprop-2-en-1-one, 95.0%, 500g

3-Methylisoxazole-5-carbaldehyde, 95.0%, 250mg